JEMETTA HARVEY: Open Payments
NPI 1962757302 · BEECH ISLAND, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 20 payments from 10 companies in 2025. Trend: 2023 $151 · 2024 $364 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $166 |
| Exact Sciences Corporation | 5 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $97 |
| AstraZeneca Pharmaceuticals LP | 1 | $80 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Novo Nordisk Inc | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: QULIPTA, CAPLYTA, The Cologuard Plus Collection Kit, BREZTRI, VRAYLAR, INGREZZA, LEQVIO, Ozempic.
Industry payments across SC — which companies pay providers there.
